Alzheimer's disease is the only leading cause of death in the United States that cannot yet be prevented, slowed, or cured. 5.4 million Americans are currently living with the disease, a number projected to swell to 13.8 million by 2050 if Alzheimer's is left unchecked.
The National Alzheimer's Project Act, passed unanimously by Congress in December 2010, set the stage for the creation of a national strategic plan to address the public health crisis posed by Alzheimer's disease. Released in 2012, the National Plan to Address Alzheimer's Disease set an ambitious goal to prevent and effectively treat Alzheimer's disease by 2025.
With less than a decade to go to meet the target, how far have we come and where should future efforts be focused? As a new administration and Congress prepare to take office, what kind of leadership do we need to meet the goals set for the nation?
Join The Hill as we gather policymakers, health officials, patient advocates, and medical experts for a briefing on America's Alzheimer's goals.
Featured Speakers Include:
- Sen. Thom Tillis (R-NC), Member, Senate Special Committee on Aging
- Rep. Paul Tonko (D-NY), Member, House Energy and Commerce Committee
- Paul Aisen, MD, Director, Alzheimer's Therapeutic Research Institute, University of Southern California Keck School of Medicine
- Maria Carrillo, Chief Science Officer, Alzheimer’s Association
- Linda Elam, Deputy Assistant Secretary for Planning and Evaluation, HHS
- Teresa Osborne, Secretary, Pennsylvania Department of Aging
- Sarah Ferris, Healthcare Reporter, The Hill
- Reid Wilson, National Correspondent, The Hill
Share your thoughts on this event with @thehillevents using #Alzheimers2025
An initiative of Eli Lilly & Co.